Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, 450 Brookline Ave, LW518, Boston, MA, 02215, USA.
The Leonard P. Zakim Center for Integrative Therapies and Healthy Living, Dana-Farber Cancer Institute, Boston, MA, USA.
Support Care Cancer. 2021 Aug;29(8):4191-4194. doi: 10.1007/s00520-021-06174-0. Epub 2021 Mar 26.
The outbreak of the coronavirus disease 2019 (COVID-19) and subsequent need for disease transmission mitigation efforts have significantly altered the delivery of cancer care (e.g., rise of telemedicine), including within the field of integrative oncology. However, little has been described about how National Cancer Institute-Designated Cancer Centers have transformed integrative oncology care delivery in response to the COVID-19 pandemic. The purpose of this commentary is to describe the delivery of integrative oncology clinical services and conduct of research at The Leonard P. Zakim Center for Integrative Therapies and Healthy Living at Dana-Farber Cancer Institute during the COVID-19 pandemic. Clinical services transitioned from an array of in-person appointment-based services, such as acupuncture and massage, and group programs, such as yoga and nutrition seminars to a combination of live-streamed and on-demand virtual group programs and one-on-one virtual appointments for services such as acupressure and self-care massage. Group program volume grew from 2189 in-person program patient visits in the 6 months prior to onset of the COVID pandemic to 16,366 virtual (e.g., live-streamed or on-demand) patient visits in the first 6 months of the pandemic. From a research perspective, two integrative oncology studies, focused on yoga and music therapy, respectively, were transitioned from in-person delivery to a virtual format. Participant accrual to these studies increased after the transition to virtual consent and intervention delivery. Overall, our clinical and research observations at Dana-Farber Cancer Institute suggest that the delivery of virtual integrative oncology treatments is feasible and appealing to patients. Trial Registration: NCT03824860 (Yoga); NCT03709225 (Music Therapy).
2019 年冠状病毒病（COVID-19）的爆发以及随后为减轻疾病传播而采取的措施极大地改变了癌症治疗（例如，远程医疗的兴起）的方式，包括在肿瘤整合医学领域。然而，关于美国国立癌症研究所指定的癌症中心如何应对 COVID-19 大流行而改变肿瘤整合医学的治疗方式，却鲜有报道。本文的目的是描述在 COVID-19 大流行期间，Dana-Farber 癌症研究所 Leonard P. Zakim 综合治疗与健康生活中心的肿瘤整合医学临床服务和研究的开展情况。临床服务从一系列以面询为基础的服务（如针灸和按摩）和团体项目（如瑜伽和营养研讨会）转变为现场直播和按需虚拟团体项目以及针对阿育吠陀和自我保健按摩等服务的一对一虚拟预约。团体项目的数量从大流行前 6 个月的 2189 名现场项目患者就诊增加到大流行期间的前 6 个月的 16366 名虚拟（例如现场直播或按需）患者就诊。从研究的角度来看，两项肿瘤整合医学研究，分别侧重于瑜伽和音乐治疗，分别从现场交付转变为虚拟模式。在过渡到虚拟同意和干预交付后，这些研究的参与者人数增加。总的来说，我们在 Dana-Farber 癌症研究所的临床和研究观察表明，虚拟肿瘤整合医学治疗是可行的，并且对患者具有吸引力。试验注册：NCT03824860（瑜伽）；NCT03709225（音乐治疗）。
